The Clinical Trials Oversight Group (CTOG) provides oversight of the pathway for locally sponsored clinical trials at the University. CTOG was formed in the spring of 2021 in response to an external review to maximise the success of the clinical trials pathway. Its remit is to:Celebrate the successes of locally-sponsored clinical trials, and encourage dissemination and implementation of their findingsMonitor the implementation of the University's clinical trials strategy Review the size and composition of the portfolio of locally-sponsored clinical trialsAdvise on funding opportunities to develop locally-sponsored clinical trials CTOG terms of referenceUoE Clinical Trials Oversight Group Terms of Reference 2024 MembershipThe current members of CTOG are: Rustam Al-Shahi Salman (Chair), Clinical Director of Edinburgh Clinical Trials Unit (ECTU)Steff Lewis, Interim Director of ECTUJennifer Cusiter, Head of CMVM Research & Innovation OperationsLorna Thomson, Director of Edinburgh Research Office (ERO)Bean Dhaun, Director of Clinical Research Facility (CRF)Alasdair Gray, NHS Lothian Director of R&DCTOG is supported by the CMVM Research Office. If you have any questions about CTOG, please contact Ismar Haga (ismar.haga@ed.ac.uk) Relevant linksEdinburgh Clinical Trials UnitACCORDEdinburgh Clinical Research FacilityEdinburgh Research OfficeExternal review summary and recommendations This article was published on 2024-09-09